COMPARISON OF CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IDENTIFIED BY PHYSICIANS AS POTENTIALLY SUITABLE FOR BIOSIMILAR INFLIXIMAB VERSUS THOSE WHO WERE NOT CONSIDERED BIOSIMILAR INFLIXIMAB SUITABLE IN EUROPE (EU)

被引：0
|
作者：
Narayanan, S. [1 ]
Lu, Y. [2 ]
Hutchings, R. [2 ]
Baskett, A. [2 ]
Mentzer, S. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS84
引用
收藏
页码：A167 / A168
页数：4
相关论文
共 7 条
  • [1] COMPARISON OF CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS IDENTIFIED BY PHYSICIANS AS POTENTIALLY SUITABLE FOR BIOSIMILAR INFLIXIMAB VERSUS THOSE WHO WERE NOT CONSIDERED BIOSIMILAR INFLIXIMAB SUITABLE IN EUROPE
    Lu, Y.
    Narayanan, S.
    Hutchings, R.
    Baskett, A.
    Mentzer, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1300 - 1301
  • [2] Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab
    Yoon-Kyoung Sung
    Soo-Kyung Cho
    Dam Kim
    Soyoung Won
    Chan-Bum Choi
    So-Young Bang
    Seung-Jae Hong
    Hyoun Ah Kim
    Eun-Mi Koh
    Hye-Soon Lee
    Chang-Hee Suh
    Dae-Hyun Yoo
    Sang-Cheol Bae
    Rheumatology International, 2017, 37 : 1007 - 1014
  • [3] Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab
    Sung, Yoon-Kyoung
    Cho, Soo-Kyung
    Kim, Dam
    Won, Soyoung
    Choi, Chan-Bum
    Bang, So-Young
    Hong, Seung-Jae
    Kim, Hyoun Ah
    Koh, Eun-Mi
    Lee, Hye-Soon
    Suh, Chang-Hee
    Yoo, Dae-Hyun
    Bae, Sang-Cheol
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) : 1007 - 1014
  • [4] Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
    Marotte, Hubert
    Mammar, Nadir
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] COMPARISON OF CLINICAL CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING THEIR FIRST BIOLOGIC AND BIOLOGIC-NAIVE PATIENTS CONSIDERED BIOLOGIC-SUITABLE IN THE UNITED STATES
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
  • [6] Comparison Of Clinical Characteristics Of Patients With Rheumatoid Arthritis Receiving Their First Biologic and Biologic-Naive Patients Considered Biologic-Suitable In The United States
    Narayanan, Siva
    Lu, Yao
    Hutchings, Richard
    Baskett, Amanda
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S616 - S616
  • [7] DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL
    Gron, Kathrine
    Glintborg, Bente
    Norgaard, Mette
    Mehnert, Frank
    Stergaard, Mikkel
    Dreyer, Lene
    Krogh, Niels Steen
    Bjorner, Jakob B.
    Hetland, Merete L.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1391 - 1391
1